Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Santa Cruz Strategies is a small private consulting firm focused on public health policy rather than drug development. Publicly available records indicate the firm specializes in substance use and addiction policy work, with Geoffrey Laredo identified as a principal and co-owner. The business appears to provide advisory and consulting services related to public health, health policy, and addiction-related issues. It does not appear to operate as a biotech, pharma, therapeutics, diagnostics, CRO, or product-based healthcare company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Santa Cruz Strategies.